Opinion on Pharmaceuticals

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
CommentWire
CommentWire

Faulding's folding: a generic expansion opportunity

Published By Datamonitor
18 Jul 2001
CommentWire
CommentWire

Barr/Aventis: generic Allegra battle

Published By Datamonitor
07 Aug 2001
CommentWire
CommentWire

Barr: a major OC generic competitor

Published By Datamonitor
17 Aug 2001
CommentWire
CommentWire

Guidant/Cook: competitors in collaboration

Published By Datamonitor
24 Aug 2001
CommentWire
CommentWire

HIV drugs: patent disputes escalate

Published By Datamonitor
28 Aug 2001
Expert View
Expert View

Better never late protect your patents early

Published By Datamonitor
03 Sep 2001
CommentWire
CommentWire

Powderject: injecting some life in the company

Published By Datamonitor
16 Oct 2001
Expert View
Expert View

The pressure mounts in the anti-hypertensive market

Published By Datamonitor
19 Oct 2001
CommentWire
CommentWire

Lilly/Barr: Prozac depression signals new phase of generics

Published By Datamonitor
24 Oct 2001
Expert View
Expert View

Delivery specialists - convenient partners or dangerous rivals?

Pharmaceutical companies and drug delivery specialists once had a cozy, symbiotic relationship. But now, the growing amount of money being pumped into the specialists is providing them with the resources to go it alone. Especially as smaller companies merge into larger one-stop shops, the potential to compete with pharmaceutical companies is increasing. But will they turn into a real danger?<BR /><BR />

Published By Datamonitor
26 Oct 2001

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.